The ECG findings of hyperkalemia change as the potassium level increases. From earliest to latest, the ECG findings include: Peaked T waves best seen in the precordial leads, shortened QT interval and ...

QRS interval widening appears to be highly specific for the diagnosis of hyperkalemia in patients with end-stage kidney disease. ECG changes, in general, have poor sensitivities for hyperkalemia in ...

AliveCor has received approval from the Food and Drug Administration (FDA) to develop a non-invasive method of detecting high blood potassium levels. The startup, which chiefly focuses on monitoring ...

Please provide your email address to receive an email when new articles are posted on . Hyperkalemia is a common electrolyte disorder, especially among patients with chronic kidney disease (CKD), ...

India: An artificial intelligence (AI)-based electrocardiogram (ECG) interpretation system demonstrated high accuracy in ...

In patients with severe hyperkalemia, the Brugada syndrome ECG phenotype is associated with a high prevalence of malignant arrhythmias and all-cause mortality. Among patients with severe hyperkalemia ...

The treatment of hyperkalemia can require urgent measures. Fortunately, it can usually be preemptively managed before serum K+ values become dangerously high. The urgency with which therapy is ...

Although serum potassium monitoring is recommended to reduce the risk of hyperkalemia, only a small percentage of patients taking RAAS inhibitors are monitored. Hyperkalemia diagnosis is often missed ...

The AliveCor KardiaBand, a sensor compatible with the Apple Watch, can detect dangerous levels of potassium in blood with 94 percent accuracy. Though the US Food and Drug Administration has not yet ...

NEW YORK--(BUSINESS WIRE)--AccurKardia, an innovator in ECG-based diagnostics technology, has announced that it has received Breakthrough Device Designation by the U.S. Food and Drug Administration ...